| 摘要 |
Novel antifibrinolytically active compounds of the formula <IMAGE> I and therapeutically acceptable salt thereof, wherein R1 is selected from the group consisting of (a) alkyl groups containing 1-4 carbon atoms, (b) alkoxy groups containing 1-4 carbon atoms, <IMAGE> <IMAGE> R2 is selected from the group consisting of (a) H, (b) alkyl groups containing 1-4 carbon atoms, (c) -COOR3, wherein R3 is an alkyl group containing 1-4 carbon atoms, (d) -CONR4R5, wherein R4 and R5 are the same or different alkyl groups containing 1-3 carbon atoms; or wherein R1 and R2 represent together the radical <IMAGE> |
